Announced
Completed
NXTHERA INC / BOSTON SCIENTIFIC CORPORATION / Acquisition / Private
Synopsis
Acquisition by Boston Scientific of NxThera, a developer of the Rezum® system, a minimally invasive treatment options for men with symptoms arising from of benign prostatic hyperplasia (BPH).
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.